Hypoparathyroidism-related health care utilization and expenditure during the first postoperative year after total thyroidectomy for cancer: a comprehensive national cohort study.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 24 03 2023
accepted: 09 05 2023
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Hypoparathyroidism is the most common complication of total thyroidectomy for cancer, and requires calcium and/or vitamin D supplementation for an unpredictable period of time. The additional cost associated with this complication has not hitherto been assessed. The aim of this study was to assess the economic burden of postoperative hypoparathyroidism after total thyroidectomy for cancer in France. Based on the French national cancer cohort, which extracts data from the French National Health Data System (SNDS), all adult patients who underwent a total thyroidectomy for cancer in France between 2011 and 2015 were identified, and their healthcare resource use during the first postoperative year was compared according to whether they were treated postoperatively with calcium and/or vitamin D or not. Univariate and multivariate cost analyses were performed with the non-parametric Wilcoxon test and generalized linear model (gamma distribution and log link), respectively. Among the 31,175 patients analyzed (75% female, median age: 52y), 13,247 (42%) started calcium and/or vitamin D supplementation within the first postoperative month, and 2,855 patients (9.1%) were still treated at 1 year. Over the first postoperative year, mean overall and specific health expenditures were significantly higher for treated patients than for untreated patients: €7,233 vs €6,934 per patient (p<0.0001) and €478.6 vs €332.7 per patient (p<0.0001), respectively. After adjusting for age, gender, Charlson Comorbidity index, ecological deprivation index, types of thyroid resection, lymph node dissection and complications, year and region, the incremental cost of overall health care utilization was €142 (p<0.004). Our study found a significant additional cost in respect of health expenditures for patients who had hypoparathyroidism after thyroidectomy for cancer, over the first postoperative year. Five-year follow-up is planned to assess the impact of more severe long-term complications on costs.

Identifiants

pubmed: 37448467
doi: 10.3389/fendo.2023.1193290
pmc: PMC10338088
doi:

Substances chimiques

Calcium SY7Q814VUP
Vitamin D 1406-16-2
Calcium, Dietary 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1193290

Informations de copyright

Copyright © 2023 Benmiloud, Le Bihan, Rebaudet, Marino, Bousquet and Bouée-Benhamiche.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Rev Epidemiol Sante Publique. 2017 Oct;65 Suppl 4:S149-S167
pubmed: 28756037
Cancer. 2000 Jul 1;89(1):202-17
pubmed: 10897019
J Med Econ. 2019 Nov;22(11):1141-1152
pubmed: 31124721
Ann Endocrinol (Paris). 2021 Dec;82(6):572-581
pubmed: 34400129
Clin Endocrinol (Oxf). 2020 Feb;92(2):159-168
pubmed: 31721256
BMC Public Health. 2009 Jan 22;9:33
pubmed: 19161613
BMC Health Serv Res. 2020 Aug 26;20(1):798
pubmed: 32847565
BMJ Open. 2017 Apr 7;7(4):e013589
pubmed: 28389487
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Med Care. 2016 Feb;54(2):188-94
pubmed: 26683778
J Clin Endocrinol Metab. 2016 Jun;101(6):2273-83
pubmed: 26943719
Clin Breast Cancer. 2022 Oct;22(7):e832-e841
pubmed: 35750594
Endocr Connect. 2022 Jan 31;11(1):
pubmed: 34939939
Surgery. 2003 Feb;133(2):180-5
pubmed: 12605179
PLoS One. 2018 Oct 31;13(10):e0206448
pubmed: 30379946
Surgery. 2020 Jan;167(1):124-128
pubmed: 31570150
Langenbecks Arch Surg. 2008 Sep;393(5):667-73
pubmed: 18633639
Head Neck. 2019 Nov;41(11):3940-3947
pubmed: 31472003
Eur J Endocrinol. 2018 Jan;178(1):103-111
pubmed: 29066572
Surgery. 2020 Jan;167(1):137-143
pubmed: 31515122
Am J Epidemiol. 2011 Mar 15;173(6):676-82
pubmed: 21330339
Gland Surg. 2017 Dec;6(Suppl 1):S69-S74
pubmed: 29322024
Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):954-962
pubmed: 28544284
Clin Epidemiol. 2019 Jun 05;11:443-455
pubmed: 31239783
Arch Plast Surg. 2012 Jul;39(4):412-6
pubmed: 22872847
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Ann Surg Oncol. 2011 May;18(5):1293-9
pubmed: 21088914
Br J Surg. 2018 Sep;105(10):1313-1318
pubmed: 29663312

Auteurs

Fares Benmiloud (F)

Department of Endocrine Surgery, Hôpital Privé de Provence, Aix-en-Provence, France.
Department of Endocrine Surgery, Hôpital Européen Marseille, Marseille, France.

Christine Le Bihan (C)

Department of Health Data and Assessment, French National Cancer Institute (Institut National du Cancer, INCa), Boulogne-Billancourt, France.

Stanislas Rebaudet (S)

Department of Endocrine Surgery, Hôpital Européen Marseille, Marseille, France.
Aix-Marseille Institute of Public Health, Institut des sciences de la santé publique d'Aix-Marseille (ISSPAM), Sciences économiques et sociales de la santé & traitement de l'information médicale Unité mixte de recherche (SESSTIM), Aix-Marseille Univ, Institut national de la santé et de la recherche médicale (INSERM), Institut de recherche pour le développement (IRD), Marseille, France.

Patricia Marino (P)

Institut Paoli-Calmettes Sciences économiques et sociales de la santé & traitement de l'information médicale Unité mixte de recherche (SESSTIM UMR) 1252, Institut national de la santé et de la recherche (INSERM), Institut de recherche pour le développement (IRD), Aix Marseille University, Marseille, France.

Philippe-Jean Bousquet (PJ)

Department of Health Data and Assessment, French National Cancer Institute (Institut National du Cancer, INCa), Boulogne-Billancourt, France.
Institut Paoli-Calmettes Sciences économiques et sociales de la santé & traitement de l'information médicale Unité mixte de recherche (SESSTIM UMR) 1252, Institut national de la santé et de la recherche (INSERM), Institut de recherche pour le développement (IRD), Aix Marseille University, Marseille, France.

Elsa Bouée-Benhamiche (E)

Department of Health Data and Assessment, French National Cancer Institute (Institut National du Cancer, INCa), Boulogne-Billancourt, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH